Navigating veterans with an abnormal prostate cancer screening test: a quasi-experimental study

Table 3 Summary of analyses of time to diagnostic resolution (Time 1) and time to treatment initiation (Time 2)

Analysis	Category	Study arm	Sample size	Event	Median days	Log rank p-value	Adj. H.R.^a	Adj. 95% C.I.	Adj. p-value
Time 1: Time from abnormal screening to diagnostic resolution
Time 1 stratified by diagnostic resolution time interval	0-80 days	Navigated	245	95 (38.8%)	68^b		0.91		0.53
		Control	245	96 (39.2%)	55^b	0.45		0.67 – 1.23
	81-365 days	Navigated	146	116 (79.4%)	151		1.41		0.01
		Control	148	107 (72.3%)	190	0.015		1.07 - 1.86
Time 2: Time from diagnostic resolution to treatment initiation
Time 2 overall	0-365 days	Navigated	84	75 (89.3%)	93		1.15		0.41
		Control	86	79 (91.9%)	87	0.36		0.82 - 1.62

Abbreviations: H.R. hazard ratio.
^aFor Time 1, age (< 65, ≥ 65) and race (African American, non-African American) were used as covariates. For Time 2, age (< 65, ≥ 65), race (African American, non-African American), and Gleason score (≤ 6, > 6) were used as covariates.
^b25th percentile since median not attained.

ISSN: 1472-6963